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Introduction
Atrial Fibrillation (AF) is a common abnormal heart rhythm
that is associated with five times the risk of stroke and twice
the risk of death. However, this risk can be reduced by ap-
proximately two thirds through the appropriate use of antico-
agulation (AC).
Objectives and Approach
Reducing the incidence of stroke through effective manage-
ment of AF is a priority recognised by Abertawe Bro Mor-
gannwg University Health Board (ABMUHB), in Wales, UK.
An understanding of how closely services follow appropriate
clinical guidelines for stroke prevention allows identification
of opportunities to improve stroke outcomes and service effi-
ciency. This study was commissioned to describe the nature
of antithrombotic drug prescribing in ABMUHB patients with
AF according to thromboembolic and bleeding risk status, and
the numbers of non-anticoagulated patients with AF present-
ing with stroke. This study was completed using linked data
held in the Secure Anonymised Information Linkage (SAIL)
databank.
Results
AF was identified in 12,778 ABMUHB patients (approximately
3% of the population), with 97% providing linked primary care
records for our required period of follow-up. Of the AF pa-
tients with linked prescribing data, 60.5% were prescribed an-
ticoagulants, 15.8% were prescribed antiplatelet agents and
23.7% received no antithrombotic medication. Notably, the
thromboembolic risk and bleeding risk profiles (characterised
by modified CHA2DS2-VASc and HAS-BLED scores respec-
tively, implemented within the SAIL databank data) were re-
markably similar in those receiving and those not receiving
AC. 965 patients were admitted to ABMUHB hospitals with
a stroke during 2015. AF was previously diagnosed in 18% of
these patients, of whom just over half (50.3%) were not being
prescribed AC during the 3 months prior to their stroke.
Conclusion/Implications
This study demonstrates under prescribing of AC in patients
with AF, which is not explained by stroke risk or bleeding
scores. ABMUHB colleagues are developing strategies for ser-
vice improvements, with plans for further sequential analysis
to evaluate the effectiveness of implemented measures for out-
come monitoring and reporting purposes.
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